Advertisement

Advertisement

SE:ISOFOL Stock Latest News

Isofol publishes 2025 reports as arfolitixorin program shows progress

Company AnnouncementsIsofol publishes 2025 reports as arfolitixorin program shows progress

Isofol Raises 18.9 MSEK via TO1 Warrant Exercise and Directed Share Issue

PremiumCompany Announcements

Isofol Raises 18.9 MSEK via TO1 Warrant Exercise and Directed Share Issue

12d ago

Isofol Extends Arfolitixorin Rights Into Autism While Keeping Cancer Focus

PremiumCompany Announcements

Isofol Extends Arfolitixorin Rights Into Autism While Keeping Cancer Focus

25d ago

Isofol Sets TO1 Warrant Price and Exercise Window, Targets SEK 19 Million Raise

PremiumCompany Announcements

Isofol Sets TO1 Warrant Price and Exercise Window, Targets SEK 19 Million Raise

1M ago

Isofol Secures Stakeholder Support Covering 42% of Upcoming TO1 Warrant Exercise

PremiumCompany Announcements

Isofol Secures Stakeholder Support Covering 42% of Upcoming TO1 Warrant Exercise

1M ago

Isofol to Add Major Shareholder Christian Haglund to Expanded Board

PremiumCompany AnnouncementsIsofol to Add Major Shareholder Christian Haglund to Expanded Board

1M ago

Isofol to Showcase Cancer Drug Candidate at Key March Investor Events

Company Announcements

Isofol to Showcase Cancer Drug Candidate at Key March Investor Events

1M ago

Isofol Reports Strong Early Data for Arfolitixorin in Difficult-to-Treat Colorectal Cancer

Company Announcements

Isofol Reports Strong Early Data for Arfolitixorin in Difficult-to-Treat Colorectal Cancer

2M ago

Isofol strengthens arfolitixorin program with new EU patent and advancing trials

PremiumCompany Announcements

Isofol strengthens arfolitixorin program with new EU patent and advancing trials

2M ago

Isofol Showcases Arfolitixorin Trial Design at ASCO GI as Phase Ib/II Study Advances

PremiumCompany Announcements

Isofol Showcases Arfolitixorin Trial Design at ASCO GI as Phase Ib/II Study Advances

3M ago

Isofol Medical to Showcase Arfolitixorin at Upcoming Investor Meetings

PremiumCompany Announcements

Isofol Medical to Showcase Arfolitixorin at Upcoming Investor Meetings

4M ago

Isofol Medical Secures New Patent for Cancer Drug Candidate Arfolitixorin

PremiumCompany Announcements

Isofol Medical Secures New Patent for Cancer Drug Candidate Arfolitixorin

5M ago

Isofol Medical AB Reports Key Developments in Interim Report

PremiumCompany AnnouncementsIsofol Medical AB Reports Key Developments in Interim Report

5M ago

Isofol Medical AB Appoints Nomination Committee for 2026 AGM

Company Announcements

Isofol Medical AB Appoints Nomination Committee for 2026 AGM

5M ago

Isofol Medical AB to Host Investor Meeting on Arfolitixorin Progress

Company Announcements

Isofol Medical AB to Host Investor Meeting on Arfolitixorin Progress

6M ago

Isofol Medical AB to Present at ESMO Cancer Congress

PremiumCompany Announcements

Isofol Medical AB to Present at ESMO Cancer Congress

6M ago

Isofol Medical Advances Arfolitixorin Clinical Study with Promising Results

PremiumCompany Announcements

Isofol Medical Advances Arfolitixorin Clinical Study with Promising Results

6M ago

Isofol Completes Share Transfer to Solasia Pharma, Strengthening Partnership

PremiumCompany Announcements

Isofol Completes Share Transfer to Solasia Pharma, Strengthening Partnership

7M ago

Isofol Medical AB Strengthens Financial Position Amid Ongoing Clinical Developments

PremiumCompany Announcements

Isofol Medical AB Strengthens Financial Position Amid Ongoing Clinical Developments

8M ago

Isofol Medical to Present Q2 2025 Interim Report

PremiumCompany AnnouncementsIsofol Medical to Present Q2 2025 Interim Report

8M ago

Isofol Medical Announces Change in Shares and Votes

Company Announcements

Isofol Medical Announces Change in Shares and Votes

9M ago

Isofol Medical Secures FDA Support for Arfolitixorin Development

Company Announcements

Isofol Medical Secures FDA Support for Arfolitixorin Development

9M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >